Lessons from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can We Fuel the Tumor Microenvironment in Gliomas?
Despite recent advancements in cancer immunotherapy, many patients with gliomas and glioblastomas have yet to experience substantial therapeutic benefits. Modulating the tumor microenvironment (TME) of gliomas, which is typically “cold”, is crucial for improving treatment outcomes. Clinical tumor sp...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-08-01
|
| シリーズ: | Vaccines |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2076-393X/12/8/862 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|